Durando A - Search Results

1

Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.

Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP. Levesque MA, et al. Among authors: durando a. Clin Cancer Res. 2000 Aug;6(8):3260-70. Clin Cancer Res. 2000. PMID: 10955812

2

Exercise and pregnancy: a review of maternal and fetal effects.

Revelli A, Durando A, Massobrio M. Revelli A, et al. Among authors: durando a. Obstet Gynecol Surv. 1992 Jun;47(6):355-67. Obstet Gynecol Surv. 1992. PMID: 1614678 Review. No abstract available.

3

Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study.

Deltetto F, Durando A, Camanni M, Pesola D, Sberveglieri M, Arese P, Massobrio M. Deltetto F, et al. Among authors: durando a. Eur J Gynaecol Oncol. 1997;18(3):185-7. Eur J Gynaecol Oncol. 1997. PMID: 9174832 Clinical Trial.

4

Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection.

Zanon C, Durando A, Geuna M, Clara R, Mobiglia A, Massobrio M, Palestro G, Pourshayesteh A. Zanon C, et al. Among authors: durando a. Am J Clin Oncol. 1998 Aug;21(4):392-7. doi: 10.1097/00000421-199808000-00015. Am J Clin Oncol. 1998. PMID: 9708640

5

Fragment analysis of the p53 gene in ovarian tumors.

Lianidou ES, Angelopoulou K, Katsaros D, Durando A, Massobrio M, Diamandis EP. Lianidou ES, et al. Among authors: durando a. Clin Biochem. 1998 Oct;31(7):551-3. doi: 10.1016/s0009-9120(98)00061-7. Clin Biochem. 1998. PMID: 9812175 No abstract available.

6

Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.

Bellino R, Cortese P, Danese S, De Sanctis C, Durando A, Genta F, Grio R, Giardina G, Katsaros D, Massobrio M, Richiardi G, Vicelli R. Bellino R, et al. Among authors: durando a. Anticancer Res. 2000 Nov-Dec;20(6C):4825-8. Anticancer Res. 2000. PMID: 11205227 Clinical Trial.

7

Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma.

Venturini M, Durando A, Garrone O, Colozza MA, Contu A, Stevani I, Genta F, Bighin C, Lambiase A, Del Mastro L. Venturini M, et al. Among authors: durando a. Cancer. 2003 Mar 1;97(5):1174-80. doi: 10.1002/cncr.11203. Cancer. 2003. PMID: 12599222 Free article. Clinical Trial.

8

Metaplastic breast carcinoma: pathology and clinical outcome.

Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, Bertone E, Grio R, Massobrio M. Bellino R, et al. Among authors: durando a. Anticancer Res. 2003 Jan-Feb;23(1B):669-73. Anticancer Res. 2003. PMID: 12680165

9

[Biologic therapy and epithelial ovarian cancer].

Porpiglia M, Vicelli R, Durando A, Fracchioli S, Puopolo M, Katsaros D, Bellino R, Benedetto C. Porpiglia M, et al. Among authors: durando a. Minerva Ginecol. 2004 Feb;56(1):91-104. Minerva Ginecol. 2004. PMID: 14973413 Review. Italian.

10

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.

Tampellini M, Berruti A, Bitossi R, Gorzegno G, Alabiso I, Bottini A, Farris A, Donadio M, Sarobba MG, Manzin E, Durando A, Defabiani E, De Matteis A, Ardine M, Castiglione F, Danese S, Bertone E, Alabiso O, Massobrio M, Dogliotti L. Tampellini M, et al. Among authors: durando a. Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3. Breast Cancer Res Treat. 2006. PMID: 16670941

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters